AmerisourceBergen

Cencora, formerly known as AmerisourceBergen Corporation, stands as a prominent global pharmaceutical solutions organization. The company was formed in 2001 through the merger of AmeriSource Health Corporation and Bergen Brunswig. Operating with a clear purpose, Cencora is dedicated to creating healthier futures by improving the accessibility and efficiency of pharmaceutical development and delivery worldwide. The organization partners extensively with pharmaceutical innovators, healthcare providers, and pharmacies across the entire value chain. This collaboration aims to optimize market access for therapies, ensuring that medications reach patients effectively and reliably.

With a significant global presence, Cencora employs a substantial workforce of over 46,000 team members. These individuals contribute to positive health outcomes by facilitating the secure and dependable delivery of pharmaceuticals, healthcare products, and comprehensive solutions. The company's operations span numerous countries, including major distribution networks in the United States and Canada, as well as packaging facilities in the U.S. and the United Kingdom. Cencora's core business revolves around pharmaceutical distribution, but it has strategically expanded its platform to include a wide array of pharma and biopharma services. These services are designed to support pharmaceutical innovation, from pre-commercialization and clinical trial stages to broad market availability and patient adherence programs. The company handles a significant portion of all pharmaceuticals sold and distributed in the United States and serves a diverse clientele, including acute care hospitals, retail pharmacies, medical clinics, and veterinary practices. In August 2023, AmerisourceBergen officially rebranded to Cencora, a name chosen to reflect its unified global presence and its central role in healthcare.